Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Scandinavian Journal of Gastroenterology|May 4, 2018
Biologics and immunomodulators for treating Crohn's disease developing after surgery for an initial diagnosis of ulcerative colitis: a review of current literatureAbhijeet Yadav, Joshua Foromera, Kenneth R Falchuk, et al.
Inflammatory Bowel Diseases|May 17, 2017
Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel DiseaseAbhijeet Yadav, Joshua Foromera, Ilana Feuerstein, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2018
Meta-analysis comparing the efficacy and adverse events of biologics and thiopurines for Crohn's Disease after surgery for ulcerative colitisAbhijeet Yadav, Satya Kurada, Joshua Foromera, et al.
Journal of Clinical Gastroenterology|November 16, 2018
Variations in Insurance Policies Regarding Adherence to the AGA Guideline for Therapeutic Drug Monitoring in IBDAbhijeet Yadav, Pamela Vasquez, Natasha H Dolgin, et al.
Drugs in Context|May 9, 2019
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenanceKartikeya Tripathi, Joseph D Feuerstein
Gastroenterology Research and Practice|June 20, 2015
Optimizing the Care and Health of Women with Inflammatory Bowel DiseaseJudy Nee, Joseph D Feuerstein
Annals of Internal Medicine|March 4, 2024
In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 yAaron Hakim, Joseph D Feuerstein
Gastroenterology Clinics of North America|August 12, 2014
Miscellaneous adverse events with biologic agents (excludes infection and malignancy)Joseph D Feuerstein, Adam S Cheifetz
Mayo Clinic Proceedings|September 10, 2014
Ulcerative colitis: epidemiology, diagnosis, and managementJoseph D Feuerstein, Adam S Cheifetz
Pageof 14